Annual report pursuant to Section 13 and 15(d)

Equity (Details Narrative)

Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended			12 Months Ended
	Aug. 21, 2022	Apr. 27, 2021	Apr. 19, 2021	Sep. 30, 2022	Sep. 30, 2021
Common stock shares acquired by related parties			679,000
Restricted stock available to be granted under amended plan				4,858,000
Stock options available to be granted under amended plan				5,073,000
Common stock share issued				114,450,000	114,100,000
Warrant [Member]
Weighted average remaining contractual life				2 years 6 months	3 years 6 months
Weighted average exercise price per share				$ 2
Warrants outstanding				77,000
Directors and officers [Member]
Restricted shares vested and granted	350,000				600,000
Stock Option [Member]
Stock options granted under amended plan				940,000	525,000
Stock Option [Member] \| Warrants [Member]
Share-based compensation expense				$ 342	$ 445
Unrecognized compensation expense				$ 585
Weighted average vesting period				3 years 9 months 14 days
2013 Incentive Stock Plan [Member]
Restricted common stock shares granted under amendment plan				100	642
Shares authorized to be granted under amended plan				15,000,000
Restricted stock available to be granted under amended Plan				7,500,000
Stock option available to be granted under amended Plan				7,500,000
Increased restricted stock and stock option grants under amended plan				10,000,000
Restricted stock and stock options available to be granted under amended plan				9,931,000
Security Agreement [Member]
Common stock share issued			83,333,000
Public offering price per share		$ 0.60	$ 0.60
Proceeds from sale of option shares		$ 6,937
Additional shares of common stock		12,500,000
Net proceeds of public offering			$ 45,478
Gross proceeds of public offering			$ 50,000
Restricted Stock [Member]
Share-based compensation expense				$ 293	$ 525
Unrecognized compensation expense				$ 322
Weighted average vesting period				3 years 29 days
Series A Preferred Stock [Member]
Preferred stock shares authorized				20,000,000
Designated preferred stock shares				1,000,000
Series B Preferred Stock [Member]
Designated preferred stock shares				5,950,000
Preferred stock shares issued				5,926,000
Series C Preferred Stock [Member]
Designated preferred stock shares				3,000,000
Preferred stock shares issued				2,093,000
Preferred stock, liquidation preference per share				$ 1.00